Akebia Therapeutics, Inc. (AKBA)
1.22
+0.04
(+3.39%)
USD |
NASDAQ |
Feb 23, 16:00
1.22
0.00 (0.00%)
After-Hours: 19:59
Akebia Therapeutics Market Cap : 323.75M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ardelyx, Inc. | 1.396B |
| ACADIA Pharmaceuticals, Inc. | 4.187B |
| Alnylam Pharmaceuticals, Inc. | 43.71B |
| Savara, Inc. | 1.164B |
| BioMarin Pharmaceutical, Inc. | 12.04B |
Market Cap Related Metrics
| PS Ratio | 1.363 |
| Price to Book Value | 7.784 |
| Price to Free Cash Flow | 9.535 |
| Price | 1.22 |
| Earnings Yield | -6.24% |
| Operating PE Ratio | 17.29 |